Vallon, Volker
Thomson, Scott C.
Funding for this research was provided by:
Boehringer Ingelheim
U.S. Department of Veterans Affairs
National Institutes of Health (R01DK56248)
Bristol-Myers Squibb
Article History
Received: 12 September 2016
Accepted: 17 October 2016
First Online: 22 November 2016
Funding
: The authors work was supported by the National Institutes of Health (R01DK56248, R01DK106102, P30DK079337), the Department of Veterans Affairs and investigator-initiated research grants by Bristol-Myers Squibb and Boehringer Ingelheim.
: Over the last 36 months, VV has served as a consultant and received honoraria from Boehringer Ingelheim, Intarcia Therapeutics, Astra-Zeneca, Janssen Pharmaceutical, Eli Lilly and Merck, and received grant support for investigator-initiated research from Boehringer Ingelheim, Astra-Zeneca, Fresenius, Janssen and Bayer. Over the past 36 months, SCT has received research support from Merck and Pfizer. The study sponsors were not involved in the design of the study; the collection, analysis and interpretation of data; writing the report; or the decision to submit the report for publication.
: All authors were responsible for drafting the article and revising it critically for important intellectual content. All authors approved the version to be published.
Free to read: This content has been made available to all.